QA approval – Pharma GMP

Audit Documentation for Completeness Before Final GMP Approval

digi — Sun, 12 Oct 2025 01:37:41 +0000

Audit Documentation for Completeness Before Final GMP Approval Do Audit GMP Documentation for Completeness Prior to Final Approval Remember: Always review GMP records for completeness and accuracy before approving any batch, report, or deviation closure — missing documentation equals non-compliance. Why This Matters in GMP In GMP environments, documentation is the backbone of compliance. Every...

Don’t Reassign Lots Without a Verified and Traceable Audit Trail

digi — Tue, 26 Aug 2025 22:13:36 +0000

Don’t Reassign Lots Without a Verified and Traceable Audit Trail Do Not Reassign Product Lots Without Maintaining a Verified Audit Trail Remember: Never change or reassign lot numbers without a fully documented and traceable audit trail authorized by Quality Assurance. Why This Matters in GMP Lot numbers are unique identifiers that allow pharmaceutical companies to...

Never Change Sampling Procedures Mid-Study Without Documented Justification

digi — Thu, 31 Jul 2025 09:55:04 +0000

Never Change Sampling Procedures Mid-Study Without Documented Justification Do Not Change Sampling Procedures During Ongoing GMP Studies Remember: GMP mandates that sampling procedures remain fixed throughout the study. Any deviation must be pre-approved by QA and supported by documented justification. Why This Matters in GMP Sampling is a critical component in the verification of product...

Issue Batch Records Only with QA Approval and Stamped Copies in GMP

digi — Wed, 30 Jul 2025 19:41:03 +0000

Issue Batch Records Only with QA Approval and Stamped Copies in GMP Release Batch Records Only After QA Stamping and Approval Remember: GMP dictates that all batch manufacturing records (BMRs) be issued through QA, stamped, and controlled to ensure data integrity, document traceability, and regulatory compliance. Why This Matters in GMP The Batch Manufacturing Record...

Don’t Discard QC Samples Without Prior QA Clearance in GMP

digi — Sun, 20 Jul 2025 00:07:26 +0000

Don’t Discard QC Samples Without Prior QA Clearance in GMP Never Discard QC Samples Without Prior QA Authorization Remember: QC samples must not be discarded unless QA has reviewed, approved, and documented the action to ensure compliance and traceability. Why This Matters in GMP Quality Control (QC) samples—including raw material, in-process, finished product, and stability...

Never Blend Different Product Lots Without Prior QA Approval

digi — Tue, 15 Jul 2025 02:34:16 +0000

Never Blend Different Product Lots Without Prior QA Approval Do Not Blend Product Lots Without QA-Approved Justification Remember: GMP strictly forbids blending of different product lots unless there is written QA approval supported by scientific and regulatory justification. Why This Matters in GMP Blending of lots, especially without understanding the root cause of rejection or...

Do Not Reprocess Materials Without QA-Approved Protocol in GMP

digi — Tue, 01 Jul 2025 10:38:20 +0000

Do Not Reprocess Materials Without QA-Approved Protocol in GMP Never Reprocess Materials Without QA-Approved GMP Protocol Remember: GMP strictly prohibits material reprocessing unless it is pre-approved by QA through a validated, documented protocol. Why This Matters in GMP Reprocessing refers to the introduction of intermediate or final product back into the process due to failure...

Never Use Trial Batches for Commercial Release Under GMP

digi — Fri, 16 May 2025 09:08:25 +0000

Never Use Trial Batches for Commercial Release Under GMP Trial Batches Must Never Be Released for Commercial Sale Remember: Trial or test batches are meant for validation, not market release. Only GMP-compliant commercial batches may be distributed. Why This Matters in GMP Trial batches are manufactured during early development, scale-up, or process validation. They are...